SCHEMBL7084949

SCHEMBL7084949

CN(C)c1ccc(-c2cccc3cc[nH]c23)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.46
KDM4E B2RXH2 1/20 0.45
RAB9A P51151 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
AHR P35869 1/20 0.42
BCHE P06276 2/20 0.41
REN P00797 2/20 0.40
NR3C1 P04150 3/20 0.39
KEAP1 Q14145 1/20 0.38
BRD4 O60885 2/20 0.37
CREBBP Q92793 1/20 0.37
PGR P06401 1/20 0.37
NR3C2 P08235 1/20 0.37
AR P10275 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ALDH1A1 P00352 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37
PDPK1 O15530 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24034931 0.81 AHR (0.46) AHRBCHERENNR3C1KEAP1
SCHEMBL594405 0.78 AHR (0.50) MAPTAHRRENNR3C1KEAP1
SCHEMBL27487511 0.77 AHR (0.46) MAPTNPSR1AHRBCHEREN
SCHEMBL6089266 0.77 AHR (0.46) AHRBCHERENNR3C1KEAP1
SCHEMBL5659443 0.77 REN (0.49) RAB9AAHRBCHERENNR3C1
SCHEMBL7091090 0.77 AHR (0.42) RAB9AAHRBCHERENNR3C1
SCHEMBL31492457 0.75 AHR (0.60) AHRBCHERENNR3C1KEAP1
SCHEMBL5662384 0.74 KEAP1 (0.46) MAPTAHRBCHERENNR3C1
SCHEMBL18000230 0.74 PIK3CD (0.54) MAPTKDM4ERAB9AAHRREN
SCHEMBL6251056 0.74 AHR (0.46) AHRBCHERENNR3C1KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030203959-A1 Novel modulators of potassium channels 4SC AG (DE) 2003-10-30 US disclosed
WO-2003074047-A1 INDOLE DERIVATIVES AS MODULATORS OF POTASSIUM CHANNELS 4SC AG (DE) 2003-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030203959-A1 Novel modulators of potassium channels HCN3, KCNN3, KCNN1 MAPT 4860/4885KDM4E 2893/4885RAB9A 3394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.